Shuyan Gu
Overview
Explore the profile of Shuyan Gu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
743
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun X, Zhen X, Liu K, Yang W, Gu S, Zhang X, et al.
BMC Musculoskelet Disord
. 2025 Mar;
26(1):220.
PMID: 40045252
Purpose: To estimate the health-related quality of life (HRQoL) of knee osteoarthritis outpatients in China overall and by body mass index (BMI), and to explore the factors associated with knee...
2.
Sun X, Zhen X, Gu S, Liu K, Yang W, Dong H
Expert Rev Pharmacoecon Outcomes Res
. 2024 Sep;
25(2):245-256.
PMID: 39340167
Objectives: To estimate the cost-utility of duloxetine compared with that of a placebo, common traditional nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2) inhibitors for the treatment of osteoarthritis (OA) from...
3.
Gu S, Gu J, Wang X, Wang X, Li L, Gu H, et al.
Health Econ Rev
. 2024 Apr;
14(1):26.
PMID: 38564113
Background: To estimate the long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin as an add-on therapy for type 2 diabetes patients inadequately controlled on metformin in China, to better inform healthcare...
4.
Zhao Z, Gu S, Yang Y, Wu W, Du L, Wang G, et al.
BMC Cancer
. 2024 Jan;
24(1):73.
PMID: 38218803
Introduction: Several studies have proved that Polygenic Risk Score (PRS) is a potential candidate for realizing precision screening. The effectiveness of low-dose computed tomography (LDCT) screening for lung cancer has...
5.
Xu B, Song B, Chang S, Gu S, Xi H
Prev Med Rep
. 2024 Jan;
37:102548.
PMID: 38186658
This study aims to investigate the extent to which the public engages in imitative behavior in their vaccination decisions for newly developed vaccines in the Chinese context. Given the crucial...
6.
Gu S, Jia C, Shen F, Wang X, Wang X, Gu H
Qual Life Res
. 2023 Nov;
33(3):691-703.
PMID: 38032396
Purpose: This study aimed to explore the effects of community-based home health care (HHC) on the physical and mental health of older adults with chronic diseases in China. Methods: The...
7.
Hu X, Gu S, Zhen X, Sun X, Gu Y, Dong H
Eur J Ageing
. 2022 Dec;
19(4):1167-1179.
PMID: 36506673
This study aims to investigate the age, period, and cohort effects on trends in activities of daily living (ADL) disability among Chinese older adults; and to explore these three temporal...
8.
Gu S, Hu X, Shi L, Zhen X, Sun X, Huang M, et al.
J Clin Med
. 2022 Dec;
11(23).
PMID: 36498669
Background: There are multiple glucose-lowering drugs available as alternative initial monotherapy for type 2 diabetes patients with contraindications or intolerance to metformin. However, little comparative and systematic data are available...
9.
Wang J, Li T, Ge J, Zhou M, Walker A, Chen J, et al.
Res Social Adm Pharm
. 2022 Nov;
19(3):495-501.
PMID: 36357271
Background: The COVID-19 vaccination booster can effectively protect the elderly from infection while also lowering the risk of serious illness and death. However, barriers remain in willingness of the elderly...
10.
Gu S, Hu X, Zhen X, Shi L, Shao H, Sun X, et al.
J Clin Med
. 2022 Sep;
11(18).
PMID: 36143082
Background: Multiple glucose-lowering drugs are available as add-ons to metformin for a second-line treatment for type 2 diabetes. However, no systematic and comparative data are available for them in China....